Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2026-07-09 @ 5:35 AM
Study NCT ID:
NCT00062751
Status:
COMPLETED
Last Update Posted:
2011-04-15
First Post:
2003-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3066A1-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Director, Clinical Trial Disclosure Group
Old Organization:
Pfizer, Inc
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |